A Phase I Dose Escalation (De) Study Of Erk Inhibitor, Ly3214996, In Advanced (Adv) Cancer (Ca) Patients (Pts).Shubham Pant,Johanna C. Bendell,Ryan J. Sullivan,Geoffrey Shapiro,Michael Millward,Gu Mi,Eunice Yuen,Melinda D. Willard,Dan Wang,Sajan Joseph,William T. McMillen,Shripad V. Bhagwat,Ramon Velasquez Tiu,Manish R. PatelJOURNAL OF CLINICAL ONCOLOGY（2019）引用 21|浏览41暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
